Trump ends Harris’ Secret Service detail
President Trump has revoked former Vice President Kamala Harris’ Secret Service protection, according to Harris spokesperson Kirsten Allen.
It’s typical that former vice presidents only have Secret Service protection for 6 months after they leave office. That would have meant Harris would have lost her protection after July. But she had received an extension. Trump is revoking that extension.
This comes as Harris is about to embark on a nationwide tour to promote her new book, 107 Days, a recounting of her historically short run for president last year.
“The Vice President is grateful to the United States Secret Service for their professionalism, dedication, and unwavering commitment to safety,” Allen told NPR in a statement.
Harris currently lives in Los Angeles, where she has been since she left Washington in January.
Trump has also revoked Secret Service detail for the adult children of former President Joe Biden.
PBS cuts 15% of jobs in wake of federal funding cut
After Congress clawed back public media funding PBS cuts 15% of its staff. More than 100 jobs jobs are being lost.
President Trump plans to rename the Defense Department as the Department of War
The change would return the department to a name that it carried for much of its history, until it became the Department of Defense in the wake of World War II.
The U.S. is designating Ecuador’s largest gangs as terrorists
The U.S. is designating Ecuador's two largest gangs — Los Choneros and Los Lobos — as foreign terrorist organizations.
For mixed status families, deportation fears cast shadow over new academic year
As the new school year begins, mixed immigration status families face heightened fears about ICE enforcement near schools, creating anxiety that extends far beyond the classroom.
Senators from both parties grilled RFK Jr. on vaccines and more
In a blistering hearing, Senators from both parties challenged the health secretary to defend his actions, including on vaccines access and CDC leadership.
Why the medical community is thrilled by U.S. support for a ‘breakthrough’ HIV drug
Lenacapavir has the potential to end the HIV epidemic, researchers say. The Trump administration says backing this kind of effort will be a model for how it does global health work in the future.